Cargando…
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy
BACKGROUND: The role of second-line chemotherapy in advanced biliary cancers (ABCs) has only recently been established in phase III randomized trial and the optimal selection of patients most likely to benefit from it remains challenging. METHODS: A cohort of 98 ABC treated second-line chemotherapy...
Autores principales: | Salati, Massimiliano, Marcheselli, Luigi, Messina, Carlo, Merz, Valeria, Messina, Marco, Carotenuto, Pietro, Caputo, Francesco, Gelsomino, Fabio, Spallanzani, Andrea, Reggiani Bonetti, Luca, Caramaschi, Stefania, Luppi, Gabriele, Dominici, Massimo, Ghidini, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906899/ https://www.ncbi.nlm.nih.gov/pubmed/35283642 http://dx.doi.org/10.2147/CMAR.S346235 |
Ejemplares similares
-
The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting
por: Salati, Massimiliano, et al.
Publicado: (2021) -
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
por: Rizzo, Alessandro, et al.
Publicado: (2022) -
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center
por: Rimini, Margherita, et al.
Publicado: (2021) -
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience
por: Salati, Massimiliano, et al.
Publicado: (2023) -
Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition
por: Medici, Bianca, et al.
Publicado: (2023)